Givaudan's like-for-like sales grew 8.6% in the third quarter, almost double the 4.7% growth analysts had expected, as demand for luxury perfumes lifted its fragrance business.
The fragrance and flavour group said Fragrance & Beauty generated CHF 3.15 billion (US$3.78 billion) in the first nine months, up 8.8% like-for-like and ahead of the 8% growth recorded in the same period a year earlier. The division accounted for roughly 53% of the company's overall sales in that period.
In the third quarter alone, Fragrance & Beauty posted sales of CHF 1.14 billion (US$1.37 billion), with 13.5% LFL growth, up from 6.8% growth in the third quarter of 2025. At group level, Givaudan recorded sales of CHF 5.89 billion (US$7.08 billion) in the first three quarters.
Fine fragrance leads
Fine Fragrance sales rose 15.3% LFL, set against a competitive prior-year comparable of 18.7%. The company said the back-to-back double-digit growth points to continued resilience in the business and strong demand across the premium perfume market.
Reuters reported that analysts at Vontobel and Jefferies estimated Fine Fragrance sales grew around 31% organically in the third quarter alone. Vontobel analyst Arben Hasanaj said the acceleration should reinforce confidence in Givaudan's growth profile and resilience.
Consumer Products sales increased 9.3% LFL, against a prior-year comparable of 5.9%, suggesting fragrance demand extends beyond fine perfumery into personal, oral, home and fabric care categories.
Fragrance Ingredients and Active Beauty, by contrast, saw combined sales fall 2.5%, compared with 1.5% LFL growth in the first nine months of 2025.
Portfolio and currency effects
Givaudan's LFL figures exclude acquisitions. On a reported basis, acquisitions contributed 2.8% to Fragrance & Beauty growth over the nine-month period, while currency translation had a negative impact of 3.8%. At group level, acquisitions contributed 1.4%.
The company highlighted two transactions: the acquisitions of Belle Aire Creations for CHF 62 million (US$74.48 million) and Vollmens Fragrances for CHF 20 million (US$24 million).
Regional divergence
At group level, Asia Pacific was Givaudan's fastest-growing geography, with sales up 10.6% LFL in the first nine months of 2026, compared with 4.6% in the same period a year earlier. Within Taste & Wellbeing, the region rose 7.1% LFL, against a 0.5% decline in the same period of 2025.
South Asia, Africa and the Middle East grew 4.1% LFL, compared with 8.8% LFL in the first nine months of 2025. Europe rose 1.5% LFL, against 3.8% a year earlier, and Latin America increased 1.1% LFL, compared with 3.1%. High-growth markets increased 7.9%, versus more modest 2.7% growth in mature markets.
North America proved the most challenging region, with Taste & Wellbeing sales down 3.3% LFL, compared with a 3.9% decline in the first nine months of 2025, although the region overall grew 1.1%. Givaudan did not separate the region's financial figures by category. The company attributed the drop primarily to continued weakness in its Health and Functional Business Unit and to US tariff refunds made to Givaudan customers during the third quarter of 2026.
Market reaction
Following the update, Givaudan's shares rose nearly 7%, hitting a 15-month high. The results had a positive ripple effect on peers: Reuters reported that dsm-firmenich, Novonesis and Symrise shares rose between 1.6% and 3.1% in early trading.
Givaudan said its figures indicate a persistent appetite for fragrances among both consumers and brands, and pointed to continued potential in fine fragrances, fragrance ingredient differentiation and premiumisation. The company underlined the consistency of its growth despite geopolitical and macroeconomic volatility, saying it demonstrates market resilience.
